← Back to all trials
Not Yet Recruiting
NCT07376330
Molecular and Cellular Characterization of MALT Lymphoma
Conditions: MALT Lymphoma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 400
Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Location: IRCCS Ospedale San Raffaele Milan
Summary
Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) is an slow growing malignancy characterized by marked biological and clinical differences across different anatomical sites.
Using participants' samples and clinical information, this observational and non-interventional research aims to generate a comprehensive molecular and cellular atlas of MALT lymphoma. The results will enable the identification of biologically meaningful tumor subtypes, microenvironmental niches, and candidate biomarkers with potential relevance for the diagnosis, prognosis, and therapy of MALT lymphoma.
Eligibility Criteria
Inclusion Criteria:
1. Male or female adults 18 years or older
2. Diagnosis of extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue on histology after Jan 1st, 2000.
3. Availability of tumor material from biopsies (either frozen or formalin-fixed paraffin-embedded) (FFPE).
4. Availability of the baseline and follow-up annotations.
Exclusion Criteria:
* None
Source: ClinicalTrials.gov (NCT07376330). StuddyBuddy aggregates publicly available trial information.